Fuad El-Hibri, Director, 10% Owner at Aptevo Therapeutics Inc. (APVO), bought 30,000 shares at $0.89 ($27K) on 2019-07-22, disclosed to the SEC on 2019-07-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |